Analystreport

Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its price target lowered by analysts at UBS Group AG from $14.00 to $6.00.

Voyager Therapeutics, Inc.  (VYGR) 
Last voyager therapeutics, inc. earnings: 3/3 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.voyagertherapeutics.com